GI
ACHN

GAMCO Investors’s Achillion Pharmaceuticals ACHN Stock Holding History

GAMCO Investors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-86,210
Closed -$520K – 931
2019
Q4 		$520K Buy
+86,210
New +$499K ﹤0.01% 721

GAMCO Investors's ACHN Position: Q1 2020 in Review

GAMCO Investors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 86,210 shares — an estimated $520K sold.

GAMCO Investors first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $520K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • GAMCO Investors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • GAMCO Investors sold 86,210 Achillion Pharmaceuticals shares in Q1 2020, an estimated $520K.
  • GAMCO Investors first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • GAMCO Investors's Achillion Pharmaceuticals position peaked at $520K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on GAMCO Investors's 13F filing for Q1 2020, filed 14 May 2020.